MEGAN JAJOU: Open Payments
NPI 1710338090 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 25 payments from 13 companies in 2025. Trend: 2023 $329 · 2024 $761 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $102 |
| Organon LLC | 2 | $48 |
| Incyte Corporation | 2 | $46 |
| Amgen Inc. | 3 | $45 |
| Janssen Biotech, Inc. | 2 | $43 |
| UCB, Inc. | 1 | $38 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
| LEO Pharma Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
Products named: SKYRIZI, OPZELURA, OTEZLA, TREMFYA, Bimzelx, ILUMYA, ANZUPGO, DUPIXENT.
Industry payments across MI — which companies pay providers there.
